Pregnancy Bridge Program for Psychiatric Patients by Barnett, Adam
University of the Incarnate Word 
The Athenaeum 
Doctor of Nursing Practice 
12-2020 
Pregnancy Bridge Program for Psychiatric Patients 
Adam Barnett 
University of the Incarnate Word, abarnett@student.uiwtx.edu 
Follow this and additional works at: https://athenaeum.uiw.edu/uiw_dnp 
 Part of the Psychiatric and Mental Health Nursing Commons 
Recommended Citation 
Barnett, Adam, "Pregnancy Bridge Program for Psychiatric Patients" (2020). Doctor of Nursing Practice. 
76. 
https://athenaeum.uiw.edu/uiw_dnp/76 
This Doctoral Project is brought to you for free and open access by The Athenaeum. It has been accepted for 
inclusion in Doctor of Nursing Practice by an authorized administrator of The Athenaeum. For more information, 
please contact athenaeum@uiwtx.edu. 
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM  1 
PREGNANCY BRIDGE PROGRAM FOR PSYCHIATRIC PATIENTS 
ADAM BARNETT 
DNP PROJECT ADVISOR 
Dr. Christopher Weidlich PMHNP, PhD 
Ila Faye Miller School of Nursing and Health Professions
CLINICAL MENTOR 
Dr. Keyamo Omokuru PMHNP, DNP 
Presented to the Faculty of the University of the Incarnate Word 
 in partial fulfillment of the requirements 
for the degree of 
 DOCTOR OF NURSING PRACTICE  
UNIVERSITY OF THE INCARNATE WORD 
December 2020 
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 2 
ACKNOWLEDGEMENTS 
Words cannot express how grateful I am to work with Dr. Christopher Weidlich. His 
direction, support, and wisdom have been of the highest quality and consistent throughout the 
last 2 years. Dr. Keyamo Omokuru also demonstrated incredible perseverance as mentor. Both 
of these advanced practice nurses have enabled me to complete my Doctor of Nursing Practice  
project. I am grateful to have had both of their support and collaboration. I am thankful for all of 
the support the project organization has shown by choosing to participate and pilot this Quality 
Improvement project. I extend my most sincere thanks to all the staff that participated in the 
project. All Incarnate Word faculty have provided the finest guidance throughout this cohort’s 
three-year academic journey. I have no doubt my graduating cohort will improve nursing 
practice for the better. 
Finally, I want to express my love and thanks to my friends, family, and cohort. You all 
are the most encouraging, genuine and caring people I have had the pleasure of knowing. It has 
been a blast working with all of you. I pray we keep the bonds we created throughout the highs 
and lows of our pursuit of higher education. I certainly would not be here without you all and I 
have a great appreciation for how we stuck together these past 3 years.  
Adam Barnett
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 3 
TABLE OF CONTENTS 
LIST OF TABLES ...........................................................................................................................5 
ABSTRACT .....................................................................................................................................6 
SUPPORTING BACKGROUND INFORMATION .......................................................................7 
PROBLEM STATEMENT ..............................................................................................................8 
NEEDS ASSESSMENT ................................................................................................................10 
Readiness for Change ........................................................................................................12 
Involvement of Agency Stakeholders  ...............................................................................12 
PROJECT IDENTIFICATION ......................................................................................................13 
Purpose ...............................................................................................................................13 
Aims and Objectives ..........................................................................................................14 
SUMMARY AND STRENGTH OF EVIDENCE ........................................................................17 
METHOD ......................................................................................................................................18 
Clinical Setting ...................................................................................................................19 
Timeframe ..........................................................................................................................20 
Project Intervention ............................................................................................................20 
Evidence Based Patient Education .........................................................................21 
Human Chorionic Gonadotropin Screening ...........................................................22 
Obstetrician Collaborative Care .............................................................................22 
Ethical Considerations and IRB .........................................................................................23 
Evaluation Plan ..................................................................................................................24 
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 4 
TABLE OF CONTENTS—Continued 
RESULTS ......................................................................................................................................25 
DISCUSSION ................................................................................................................................28 
Barriers and Limitations ....................................................................................................29 
The Novel Coronavirus 2019 .............................................................................................32 
Recommendations ..............................................................................................................34 
Implications for Practice ....................................................................................................36 
REFERENCES ..............................................................................................................................39 
APPENDIX A: STANDARDIZED TRI-FOLD (FRONT) ...........................................................42 
APPENDIX B: STANDARDIZED TRI-FOLD (BACK) .............................................................43 
APPENDIX C: ORIGINAL PROJECT CHECKLIST  ................................................................ 44 
APPENDIX D: REVISED PROJECT CHECKLIST ....................................................................45 
APPENDIX E: LETTER ...............................................................................................................46 
APPENDIX F: STATEMENT OF NON-RESEARCH .................................................................47 
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 5
LIST OF TABLES 
Table Page 
1. Patients by Diagnosis……………………………………………………….………….23
2. Patients by Age and Race………………………….……………..…..…..………..…...24
3. Reasons that Patient did not need Follow-Up…………….………………..….….……25
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 6
Abstract 
The National Institute of Mental Health (2017) estimates that 9.2 million people age 18 years 
and older are diagnosed with bipolar disorder in the United States. Research has shown 
pregnancies in women with mental health problems have higher rates of poor outcomes and 
complications (Epstein et al., 2014; Freeman, 2007; Rusner et al., 2016; Scrandis, 2017). Aim. 
The purpose of this scholarly project is to provide standardized patient education, increase urine 
human chorionic gonadotropin screening rates, and to set up a gynecologic care bridge for 
patients considering pregnancy and are diagnosed with bipolar disorder. Evidence. The Centers 
for Disease Control and Prevention (2019b) estimates 51% of pregnancies are unplanned and 
recommends planning for pregnancy ahead of time. The American College of Obstetricians and 
Gynecologists (2019) recommends a multidisciplinary care team for patients that plan on 
pregnancy. Mood-stabilizing and anti-psychotic medications are known human teratogens 
(Bodén et al., 2012; Mittal et al., 2015; Stahl, 2017). Method. Female patients with bipolar 
disorder, ages 18-65 years, received standardized medication and contraception education. These 
patients were screened for pregnancy intentions or human chorionic gonadotropin. Patients that 
met criteria were connected with a gynecologic provider. Results. 158 patients were screened for 
pregnancy and offered education over ten weeks. 37 patients had recent pregnancy tests. 50 
patients were indicated for follow up. Implications. Medication safety is of paramount 
importance for this high-risk population. Data captured during this project provides a snapshot. 
This process should be continuous and championed by health care organizations. 
Keywords: medication, safety, pregnancy, mood-stabilizers, psychotropics, evidence-
based practice change 
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Supporting Background Information 
Of the 9.2 million people age 18 and older with bipolar disorder, females in this group 
have been shown to have higher rates of complications and poor pregnancy outcomes (Epstein et 
al., 2014; Freeman, 2007; National Institute of Mental Health [NIH], 2017; Rusner et al., 2016; 
Scrandis, 2017). Planning for pregnancy needs to occur ahead of time as approximately 51% of 
pregnancies are unplanned and this percentage is likely higher in those with mental health 
disorders (Centers for Disease Control and Prevention [CDC], 2019b; Rusner et al., 2016; 
Yonkers et al., 2004). It is critical to include medication planning for patients that are thinking 
about pregnancy. Research has shown that most mood-stabilizing medications are human 
teratogens (American College of Obstetricians and Gynecologists [ACOG], 2008; Bodén et al., 
2012; Stahl, 2017). In order to alleviate this issue, the ACOG (2018) recommends patients have 
a multidisciplinary care team if they are planning to become pregnant. Preventing complications 
and poor pregnancy outcomes in the mental health population is paramount for patient safety and 
to alleviate the already tremendous burden on the healthcare system. 
A care gap for both providers and patients regarding the complications associated with 
medications and psychiatric illness related to pregnancy outcomes exists in the proposed project 
site. The ACOG (2008) describes guidelines on psychiatric medication use during pregnancy and 
lactation with the purpose of reducing complications and adverse fetal effects. These guidelines 
are critical for mental health care institutions because they align with patient safety goals and 
mission principles. The ACOG highlights scientific evidence that demonstrates potential adverse 
health effects from the administration of many mood stabilizers. Medications such as lithium 
carbonate and valproic acid, as well as atypical and typical antipsychotics are used for mood 
stabilization. Birth defects effects occur in the fetus exposed to these drugs, including neural tube 
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and cranio-facial malformations (Epstein et al., 2014; Stahl, 2017). Scrandis (2017) notes that 
providers should weigh risks and benefits found in current evidence regarding the effects of these 
medications. In some cases, women should continue their medications that may increase risk to 
pregnancy outcomes. 
Irrespective of mental health, unplanned pregnancy rates range from 45%-75% 
depending on age (CDC, 2019b; Yonkers et al., 2004). On top of this, research indicates women 
with BPD have higher rates and poorer pregnancy outcomes (Rusner et al., 2016). The ACOG 
(2019) and the CDC (2019a) discuss the importance of pre-pregnancy counseling and education 
in order to reduce complications. These institutions call for a multidisciplinary approach to 
pregnancy, with the patient at the center. Patients need concrete counseling and screening prior 
to pregnancy. If a patient becomes pregnant, they should be under the care of an obstetrician and 
gynecologist (OBGYN) or other women’s health care provider in addition to their mental health 
provider.  
Problem Statement 
Many psychotropic medications pose a threat to the development of newborns in female 
patients receiving mental health treatment (ACOG, 2008; Bodén et al., 2012). This is especially 
important if special considerations are not made with respect to side effects, dosage, or the 
patient’s care is mismanaged. For instance, bipolar disorder is a chronic and severe mental health 
disorder that requires continuous mood stabilizing to lower suicide risk (Bodén et al., 2012). 
One-third of all women who become pregnant in the United States are potentially exposed to 
psychotropic medication at some point during pregnancy (ACOG, 2008).  
Moreover, simply being diagnosed at some point with a mental health condition such as 
bipolar disorder or schizophrenia has been associated with an increased risk of negative 
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pregnancy effects. In women with mental health diagnoses, there is increased prevalence of poor 
reproductive health and knowledge, and a tendency to have more sexual partners and sexually 
transmitted diseases (Epstein et al., 2014; Dinc et al., 2019). Lack of education and proper 
support for these patients can cause an increase in adverse pregnancy outcomes. Although the 
Food and Drug Administration (FDA) is stopping the use of pregnancy categories in the United 
States, the previous category ratings of most mood stabilizers were category D, meaning there 
was positive evidence of risk to the fetus. Most typical and atypical antipsychotics are category 
C, meaning risk cannot be ruled out (Epstein et al., 2014). Additionally, Haskey and Galbally 
(2017) found supporting evidence of adverse fetal outcomes in their systematic review of studies 
on medications in these categories. 
In this outpatient mental health clinic (OMHC) setting, no standardized education was 
being provided to potential mothers on the teratogenic effects of many commonly prescribed 
mood stabilizers and antipsychotics. Three providers were noted to give patients on-the-spot 
pregnancy education counseling by their provider. The OMHC also performs pregnancy 
screening either via verbal attestation or by urine or serum human chorionic gonadotropin (hCG) 
test at sporadic intervals and at the least yearly. Often, this is after the patient is exposed to 
potentially harmful medication. This process is also disjointed, as the licensed vocational nurse 
(LVN) or registered nurse (RN) questions the patient about their pregnancy intentions during 
their review of systems (ROS). They do not educate patients and are limited to questioning and 
drawing labs if the provider orders an hCG. The psychiatric-mental health nurse practitioner 
(PMHNP) conduct medication consent for psychotropic and on the spot, discretional education. 
Female patients between ages 18-65 are tested for pregnancy depending on how they respond to 
LVN/RN questions. 
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There are alternative treatments that have efficacy during pregnancy. Substantial 
evidence supports psychotherapies for managing bipolar depression, which can prevent relapse 
in some patients. “Bipolar-specific cognitive behavioral therapies, family-focused therapy, 
interpersonal and social rhythm therapy, group psycho-education, and systematic care 
management” have demonstrated effectiveness in BPD treatment (Epstein et al., 2014, p. 13). 
The proposed project site does not provide sessions with trained psychotherapists nor do they 
provide services by an OBGYN. 
Needs Assessment 
Identification of the problem included several steps: The first step was to consider the 
patient population of the OMHC. The majority of the patients at this OMHC are diagnosed with 
major depressive disorder, bipolar disorder, or schizophrenia. Next, medication prescriptions for 
mood stabilizers were evaluated. Between November 1, 2019 and January 31, 2020, 240 patients 
with one of the diagnosis codes for bipolar disorder were identified as having active an average 
of 2.1 active prescriptions. The majority of these patients are on active prescriptions for one of 
the sodium channel modulators (14.6% of prescriptions; such as valproate or lithium) or typical 
or atypical antipsychotics (85% of prescriptions; such as lurasidone or aripiprazole). These 
patients are prime candidates for education regarding pregnancy, due to generally low socio-
economic and educational status and poor insight associated with many mental health conditions 
and associated poor pregnancy outcomes (ACOG, 2008; Epstein et al., 2014). Providing an 
intervention related to the needs of the community and the practicing clinicians in this OMHC 
will advance the organization and provide a much-needed client service with positive holistic 
outcomes.  
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One of the primary measures that the organization wishes to achieve is safety of care. The 
first step in achieving this goal is education. Education for patients regarding this proposal in the 
OMHC is currently left to provider discretion. Sporadic chart reviews demonstrated providers 
commonly documented one sentence on pregnancy risk education in their notes. Other forms 
such as medication consent were sporadically completed. The medication consent listed that 
risks and benefits of medications were discussed with the patient. To better achieve patient 
safety, patients should receive standardized contraceptive counseling before taking psychotropic 
medications. Additional information regarding medication safety will aid the health care 
organization achieve its goals and improve outcomes for its childbearing age healthcare 
population.  
Another large part of process change to better adhere to guidelines is screening for 
pregnancy. LVNs or RNs accomplish reviews of systems (ROS) during patient intake. These 
staff members are supposed to ask patients about pregnancy planning during their ROS on each 
patient visit. However, many patients are unaware of their current pregnancy status or are not 
sure if they plan to become pregnant. As mentioned previously, rates of unintentional pregnancy 
are higher in the mental health population. Ideally, all patients will be pregnancy tested if 
appropriate during their visit.  
Finally, there is no follow up in place for patients that are found to be pregnant or plan to 
become pregnant. This OMHC does not provide OBGYN staff care which both the ACOG 
(2019) and the CDC (2019a) outline as part of pregnancy planning. Therefore, part of the process 
change is to implement a care bridge involving providers specialized in caring for expecting 
mothers. To close the care gap, this subpopulation of patients be linked with community 
providers that specialize in obstetric and gynecologic service.   
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Readiness for Change 
The DNP mentor and student accomplished initial conception for this project by 
considering the population and organizational needs. Assessment of the staff in the fall of 2019 
and spring of 2020 demonstrated they are open to participate in the process change. The 
organization’s readiness for change and success of this DNP proposal depend on how the 
stakeholders engage in the project. The promotion of a safe working environment is a serious 
goal and requires leadership and staff involvement. 
Involvement of Agency Stakeholders 
Program implementation required formation of a team to accomplish this DNP project. 
The DNP mentor and advisor were crucial in program proposal and development. During the 
early phases of needs assessment and throughout the planning stage in the fall of 2019, 
stakeholders were identified at the local and organizational levels. The Chief Medical Officer 
(CMO) and Treatment Care Council (TCC) for the organization were invaluable by providing 
frequent feedback and ideas for this process change.  
The proposed plan, intervention and outcomes were provided to the TCC on December 
11, 2019. The CMO, clinic & organizational leadership and various PMHNP providers were 
present and voted to proceed with the pilot intervention with guided supervision (see appendix 
W). Further follow up regarding this process change was communicated with both the local 
clinic staff and the organizational leadership throughout the planning, implementation and 
evaluation phases. 
For the first 5 weeks of the implementation period (February 17, 2020 through March 20, 
2020), the LVN and provider staff of the organization were regularly assessed for proper project 
procedures. Initially, several staff stated they were not comfortable with completing the checklist 
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or other basic tasks until a supervisor approved it. Time is a huge issue for all nursing staff and 
was regularly mentioned by 2 of the LVNs and by the case management (CM) identified to 
participate mid-way through the project. During the day, all staff see patients during business 
hours so adding a checklist to their to-do list caused noticeable anxiety and resistance to process 
change. 
Project Identification 
The IOWA model provides a simple and straightforward approach to systems change. 
The framework provides a clear feedback loop and process to guide clinical practice evaluation. 
The IOWA model dictates knowledge-focused triggers, such as implementation of 
organizational guidelines, guide evidence-based practice changes. For this project, guidelines 
provided by the ACOG (2008) and highlighted by the CDC (2019a) are the templates for this QI 
project intervention. Before implementation, the process change was in line with the proposed 
organization’s goals. These goals are to promote a comprehensive, safe, and collaborative care 
for its patients.  
With the indication of these needs, a project team was formed. A DNP project mentor 
was identified at the proposed site to provide oversight at the location. During the project 
development and before implementation, this project was presented to two tiers of leadership, 
including organizational and the local site. Faculty from the University of the Incarnate Word 
provided oversight of the DNP student. Literature regarding this QI project was identified by the 
DNP student and synthesized for supporting evidence. The accumulated and synthesized 
research supports an evidence based clinical practice pilot change on select units.  
Purpose 
The purpose of this project was to implement a three-part simultaneous process change 
governed primarily by ACOG (2008; 2019) guidelines and supported by the CDC (2019) and
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March of Dimes (2017) in the proposed site. The three parts are:  
• Standardized education for patients regarding medication risk and
contraceptive use.
• Screening for early pregnancy detection in all females.
• Follow up collaborative care for patients planning on pregnancy.
Standardized educational, hCG urine screenings and collaborative care with OBGYNs has been 
shown to reduce adverse pregnancy outcomes, allow for providers to document more 
comprehensively, and reduce potential liability of the organization. The long-term goal of this 
practice improvement project was to increase safe and effective care for female bipolar patients 
in the psychiatric outpatient community setting. 
Aims and Objectives 
This project’s focus was on primary prevention as this problem and population are 
admittedly difficult to capture. Education regarding the prevention of possible complications 
with pregnancy in the mental health population is the first step towards better outcomes. To meet 
this goal, it was necessary to review and discuss what is currently known about mood stabilizers. 
Mood stabilizing medications consist of voltage sensitive sodium channel modulators and 
antipsychotic medications, which are often used off label for this purpose (Jones & Jones, 2017; 
Stahl, 2017). The majority of the patients at this OMHC are taking one of these types of 
medications for treatment. Between November 1, 2019 and January 31, of 2020, a sample of 240 
patients revealed that 12% were on active prescriptions for Lamictal, Lithium, Depakote or 
Carbamazapine. Most prescriptions for this population in this setting were for one form of 
Abilify (31%) or Latuda (17%).  
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The objective of this project was to increase positive outcomes for pregnant female 
patients with bipolar disorder through a three-part process implementation. This evidence-based 
project aimed to implement guidelines by ACOG and the CDC on top of the highest quality 
studies regarding psychotropic medications and pregnancy. The goal was to provide standardized 
education, improve pre-conception screening of females between the ages of 18 and 65, and set 
up a pregnancy care bridge for this outpatient setting. The process begins when a patient enters 
treatment as an outpatient in the psychiatric and mental health clinic setting and the process of 
pregnancy outcome education ends when the patient is discharged to home or another facility. 
By modifying the education, screening and the follow-up process, the short-term objective was 
to assess changes in these areas for the female patient receiving psychopharmacologic treatment. 
The long-term objective is to increase psychotropic pregnancy outcomes for patients and 
providers.  
The first goal of this project is to provide standardized education to female patients 
regarding risks of psychotropic medication and their effects during pregnancy. In the OMHC, 
education was accomplished in the narrow time window the individual provider had with the 
patient during their appointment. The providers of this OMHC educated patients on the fly 
regarding risks of mood stabilizing and antipsychotic medication during pregnancy. The OMHC 
used a consent form where providers noted when they gave psychotropic medication education 
regarding pregnancy risks. Standardized medication and contraceptive specific, pregnancy trifold 
(see appendix A & B) were provided to all female patients ages 18-65 years with bipolar 
disorder. The goal was to provide this education to 100% of these patients from February 17, 
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 16 
2020 to April 24, 2020. Creation of a more objective and defined policy for education will also 
allow and facilitate provider documentation and discussion with patients regarding the risk of 
psychotropic medications. 
Along with specific education, all patients were screened for pregnancy via the one 
question initiative (ACOG, 2016). When applicable, blood or urine hCG pregnancy tests were 
supposed to be ordered by providers. Often, pregnancy testing was not conducted until after the 
patient has been prescribed medication. In order to better capture and prevent possible problems 
regarding pregnancy and medication teratogenicity, it is proposed that all females ages 18 to 65 
with bipolar disorder be screened and that urine or blood hCG be ordered when needed. The goal 
was to achieve a screening rate of 100% of females in this age group with bipolar disorder 
regardless of their response to the “one key question” (Oregon Foundation for Reproductive 
health, n.d.). 
Finally, the third goal was to refer patients for follow up care that meet criteria for 
education and screen positive for blood or urine hCG. Those patients that were pregnant or 
planning on pregnancy needed to be connected with an OBGYN according to literature review 
and guidelines (CDC, 2019a; ACOG, 2018). Establishing a collaborative bridge for pregnant 
patients by connecting them with providers that specialize in pregnancy care is the most 
important piece of this project. Therefore, 100% of patients that screen positive for pregnancy or 
plans on pregnancy should be set up with an OBGYN specialized provider to facilitate perinatal 
outcome. This was documented on the same checklist by the PMHNP provider.  
The expected outcome was to achieve 100% patient education for these patients, 
complete 100% pregnancy screening via urine or serum testing when the patient indicates it was 
needed, and involve gynecologic service for patients with bipolar disorder that wish to become 
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pregnant when applicable. Preconception health care is the first step to improve outcomes in the 
psychiatric outpatient population (CDC, 2019a). Secondly, screening for pregnancy needs to be 
accomplished on all female patients for prophylactic planning purposes. Finally, patients should 
be connected with OBGYN service for pre-pregnancy counseling and care (ACOG, 2019). These 
three interventions of pre-pregnancy education, pregnancy screening and follow up care in this 
OMHC will create an environment that promotes safety and positive outcomes for mothers and 
their children. 
Summary and Strength of Evidence 
Literature for this project was found using CINAHL, PubMed, and Google Scholar 
databases. Randomized controlled trials (RCT) and literature reviews that include them have 
been conducted to study psychotropic medications and their effects on pregnancy outcomes. The 
highest evidence shows clear adverse effect of many psychiatric medications and fetal exposure 
during pregnancy. Literature reviews support strict use of mood stabilizer use and avoidance of 
certain drugs during pregnancy (Jones & Jones, 2017; Scrandis, 2017; Stahl, 2017). Furthermore, 
Epstein et al. (2014) found few controlled studies prove medication effectiveness for pregnant 
women with bipolar disorder. 
There are ethical issues when it comes to conducting prospective randomized controlled 
trails on this type of population for obvious reasons. Administering potentially harmful 
medications to test teratogenic effects would no doubt be catastrophic (Jones & Jones 2017; 
Poels et al., 2018). Twelve articles for this project were at least level IV evidence, which 
primarily consisted of literature reviews including retrospective cohort studies or case reports. 
The committee opinions by the ACOG included the highest possible tiers of literature, but lacked 
of prospective research with randomized samples for aforementioned reasons. Nineteen articles 
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were between levels 5 and 7, meaning evidence for these studies were descriptive or qualitative 
in nature, again lacking randomization of sample cohorts, comparative analysis or controlled 
groups.     
On top of the issue with prescription medications, several other problems present with the 
psychiatric population and pregnancy. Women with bipolar disorder have often been found to 
smoke, be overweight, and misuse alcohol or other substances more than women without bipolar 
disorder (Bodén et al., 2012; March of Dimes, 2016). Along with these comorbidities, another 
major problem with the psychiatric population is street drug use. About one in twenty women 
use street drugs during pregnancy, which can lead to many of the same immediate complications 
with the fetus and labor, such as problems with the placenta or malformations such heart or other 
birth defects (March of Dimes, 2016). 
Research regarding pregnancy, mood stabilizers and antipsychotics is consistent and the 
evidence proposes a team approach to medication during pregnancy. As with most clinical 
problems, there is need for additional research (ACOG, 2008; Rusner et al., 2016; Yonkers et al., 
2004). Many studies claim medications need more randomized controlled trials in specific 
populations, but prospective research on bipolar pregnant females will always be hard to 
conduct. It is understandable that data would be lacking in this area, as the population is naturally 
evasive, non-compliant and it is hard to study medication-associated risk on expecting females 
(Epstein et al., 2014; Haskey & Galbally, 2017).  
Method 
Practice guideline number 92 by the ACOG (2008) centers on risk to the developing fetus 
safety to meet the standards of care. The ACOG and the CDC outline a standard of care when it 
comes to pregnancy recommendations for patients on mood stabilizing drugs. Over the course of 
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project implementation, staff were educated regarding their role and participation in the process 
change. Implementation of the project requires careful attention and engagement from all team 
members at the OMHC. As the intervention rolled out, daily follow was conducted to ensure the 
process is being completed properly. Front desk personnel, medical assistance and clerical staff 
were not used in this pilot program. Inclusion of the nursing (primarily LVN) staff and the 
mental health prescribers are the key professionals to perform as a team in this quality 
improvement (QI) project. Ideally, there would be a committee to chair this QI project in the 
future. The DNP student served as the primary coordinator for this project for at least 10 weeks 
of data collection. 
Clinical Setting 
The clinical setting for the intervention is an OMHC located in a large metropolitan area 
in south Texas. This site is located in the central city with supporting facilities for the 
disadvantaged mental health patient in close vicinity. The OMHC consists of the following 
healthcare (non-administrative) personnel: Numerous patient care specialists (PCSs) and medical 
assistants (MAs), seven LVNs, two RNs, four case managers (CMs), two psychiatrists, and four 
PMHNPs as well as multiple primary health care staff and providers. Health care personnel work 
8-hour shifts from 8:00 a.m. to 5:00 p.m. The OMHC is open Monday through Friday and closed 
on federal holidays. The managerial staff host meetings for the healthcare staff every week, and 
report to the board of directors at least once a month.  
A small number of staff were selected for pilot of this process change for many reasons. 
This OMHC contains three primary patient process areas, and each patient goes through up to 
four types of different patient care staff (for example, MA, LVN, PMHNP, & CM). This project 
was easier to pilot with a small selection of staff. Also, timeframe for implementation is limited 
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and there are likely improvements in process and checklist that can be made going forward. For 
these reasons, four prescribers and two associated LVNs were used for this pilot QI process 
initially. After March 20, 2020, most patients were from one provider due to changes at the clinic 
from COVID19. Five weeks of data were collected using two LVNs and the four associated 
prescribing staff. For the last 5 weeks, data was collected from home using remote access due to 
necessary social distancing measures implemented at the clinic. 
 Timeframe 
The proposed interventions were implemented over ten weeks, from February 17, 2020 
through April 24, 2020. The intervention consisted of three changes implemented at the same 
time: (a) Standardized patient education, (b) various screening methods to encompass all female 
patients ages 18-65, and (c) collaborative care referral involving OBGYN service and medication 
list for patients planning to become pregnant. Staff tasks and patient information were tallied via 
a comprehensive checklist and data collected was kept in a password secured SPSS (statistical 
package for the social sciences) data set for easy analysis. Results were compiled and data 
disseminated to leadership at the OMHC once analyzed and at their request.  
Project Intervention  
The ACOG (2016) describes the use of checklists and proper procedures for 
implementation, revision and evaluation. The simplest method to pilot change in this 
organization was the implementation of a checklist regarding the aforementioned goals. Other 
methods might be more desirable in the future, but are outside the scope of this project (see 
barriers). There were three primary sections in this checklist where staff are able to notate the 
following:  
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• Dissemination of mood stabilizer risk, contraceptive information, and
community pregnancy resources.
• Pregnancy screening.
• Description of collaborative care follow up with an OBGYN if a patient is
planning to be pregnant or is found to be pregnant through screening
(Appendix Y).
Each intervention is described in detail below. 
Evidence Based Patient Education 
The first step in improving pregnancy outcomes is patient counseling. The proposed 
educational material contains a summary of the evidence that described in multiple high-quality 
literature samples. Educational materials adhere to the recommended guidelines by the ACOG 
(2008), CDC (2019a), and relevant cited literature. An educational trifold was developed to serve 
as a practical guide for both patients and providers (Appendix A and B). Pamphlets were given 
to female patients, ages 18-65 years with any form of bipolar disorder, and consisted of three 
sections. The front part of the pamphlet included a summary of evidence regarding pre-natal 
counseling, containing advisory information regarding mood stabilizing medications and the 
need for pregnancy risk assessment with the patient’s providers. The middle section included 
recommendations for common contraceptive use, with detailed methods and effectiveness. 
Finally, the backside contained community women’s health resources, a medication-tracking 
card, and follow up procedures for women during pregnancy. The educational tri-folds were 
given to LVNs that complete the ROS for each patient and the PMHNP providers that provide 
medication management and counseling. Chart reviews were used to evaluate documentation and 
education given to this patient population. The checklist allowed for notation of the standardized 
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psychotropic medication and pregnancy recommendations. Access to the educational tri-fold was 
provided in both English and Spanish, as a large portion of this OMHC population speak 
Spanish. Tri-folds were emailed to patients when applicable by providers once social distancing 
was mandated by the local government at the project site. 
Human Chorionic Gonadotropin Screening 
Blood or urine hCG tests need to done on all female patients when applicable. The 
OMHC currently screens patients depending on how they respond to reproductive health 
questions, primarily the question, “do you plan on becoming pregnant,” by LVNs or RNs. 
Providers also ask patients about their pregnancy plans and document lab reviews in their 
evaluation and management note. Chart review revealed baseline hCG screening rates were 
approximately 97% percent prior to project start. The purpose of this project is to increase the 
screening rates to 100% by serving as a reminder to screen patients. The goal is to improve 
capture of the expecting or unplanned pregnant patient. Urine hCG screenings are administered 
by the RN or LVN staff before seeing the provider. The clinic has a policy of at least yearly 
laboratory draws and as needed hCG urine or serum testing. More data regarding pre and post-
invention screening is discussed in the results section. Both prescribers and LVNs are able to 
document on the checklist regarding screening. When social distancing was implemented, data 
were obtained via organization electronic health record (EHR) and analyzed in SPSS. 
Obstetrician Collaborative Care 
The OMHC does not provide OBGYN services and follow up care for women’s health is 
not tracked by any OMHC staff. ACOG (2019) guidelines and evidence-based literature dictate 
all patients planning to become pregnant should be under the care of an OBGYN. Pre-conception 
planning for patients with bipolar disorder should be a team effort and include the patient, 
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psychiatric provider and a women’s health specialist. The goal is to connect 100% of these 
patients with an OBGYN provider. Trends regarding pre-intervention rates were compiled via 
retrospective chart review. Post-invention referrals and collaborative care were documented on 
the one stop checklist by PMHNPs and CMs to determine effectiveness of intervention. 
This OMHC provides care to clients that are from the local zip code. Therefore, three 
clinics were identified in close proximity to the area to provide for follow up care if needed. 
There are exceptions for this, including patients that already have an OBGYN provider or do not 
live in the local area. For the purpose of this project, several local clinics specializing in low 
income, obstetric and gynecologic care were identified during planning. All three clinics were 
contacted via email or phone to assess for the type of service they provide and the type of 
funding. These clinics normally service similar client types as those that receive care at the 
project site. These clinics are local to the city and are independent clinics that provide women’s 
health services. Patients identified for follow up were presented to a case manager for follow up. 
Ethical Considerations and IRB 
This project upholds ethical considerations by avoiding collection of sensitive personal 
information, remaining focused on process improvement based, and allowing for patient right of 
refusal at any step in this process. Internal Review Board (IRB) approval is not required for the 
implementation of this QI project. Therefore, a DNP statement of non-research is included 
(Appendix X). Leadership at the OMHC provided a letter of support for implementation of the 
project at their location (Appendix W). The DNP student complied with the Health Insurance 
Portability and Accountability Act in conducting QI activities. 
Patients were allowed to refuse any part of this process. Just as well, it is unethical for a 
health care provider to dictate pregnancy needs of their patients. Pregnancy planning and 
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contraceptive choices are for patients to decide. Lack of human randomized controlled trials will 
continue in the future. Testing the teratogenicity of medications in mothers with developing 
fetuses is an ethical concern, especially considering these medications are known to be harmful. 
Evaluation Plan 
To assess effectiveness of this QI project, three primary measures are of interest. For all 
parts of the process change, percent calculations of pre and post-intervention statistics can be 
compiled. Provision and documentation statistics of pre-conception counseling, number of 
patients that are screened for urine or blood hCG, and collaborative care referrals for pregnant 
patients or patients wishing to become pregnant was tracked via the checklist. A checklist is the 
simplest method to immediately implement this process and measure changes. The checklist 
outlined process changes and allow for multiple staff to document whether or not steps are 
completed and why.  
The first step for the checklist is to document how many patients receive the standardized 
tri-fold of educational materials. It is expected that all female patients ages 18-65 years with 
bipolar disorder are educated for all four of the staff providers. Providers are expected to 
disseminate the standardized tri-fold. Provider documentation was reviewed throughout the 
process change to areas for improvement. The number of patients provided standardized 
education can be documented by LVNs and providers. Education rates and documentation were 
tracked pre and post-intervention. Pre and post-intervention screening changes were measured in 
addition to changes in OBGYN referral and collaboration rates. Data trends and changes were 
disseminated to leadership in the OMHC and at the organizational level.  
Secondly, space on the checklist was be dedicated to pregnancy screenings. Both verbal 
screening and quantitative testing were included. Both the “one key question” and blood or urine 
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hCG screening documentation was accomplished by provider or LVN staff. Although the LVNs 
are the primarily responsible for tracking initial screening, additional details can be added by the 
providers. Often times the providers have to order blood hCG depending on how the patient 
responds to pregnancy questioning during individual counseling. The LVNs complete focus 
reviews of systems for their patients.   
Finally, follow up care was evaluated pre and post-intervention via chart review. 
Providers and CMs are responsible for patient connection with OBGYN care. The checklist 
included an area to document care bridge care set up. Providers and case managers were able to 
track the number of times patients needed to connect this population with community OBGYN 
care. The goal is that all female patients ages 18-65 with bipolar disorder receive proper 
pregnancy counseling when indicated. Associated metrics were tallied for each category pre and 
post intervention (see results).   
Results 
A total of 158 patient samples were collected over a total of 10 weeks from, 17 February 
through 24 April 2020. Descriptive statistics and frequencies were used to analyze all data in this 
project. 100% of patients were screened for pregnancy plan and offered the standardized 
educational material compared to 97% before implementation of this intervention. Table 1 and 2 
specify patients by diagnoses and demographics of the sample. 
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Table 1 
Patients by Diagnosis 
Diagnosis n = 158 
Schizophrenia/schizoaffective 29 
Bipolar I 86 
Bipolar II 12 
Bipolar Disorder, Unspecified 20 
Major Depressive Disorder 11 
Note. Major depressive disorder and schizophrenia were included due to the use of similar 
medications being used to treat these patients.   
Table 2 
Patients by Age and Race 










African American 20 
Mixed/Other 5 
Table 3 outlines reasons that patients did not need additional follow up. The most 
common causes were menopause (20.9%), followed by hysterectomy (9.5%), then tubal ligation 
(7%), and birth control (8.2%). Nine patients refused further questioning. Two sets of eight 
patients each stated they had the same sex partner or were abstinent from sex. In total, 68% of 
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patients screened did not need follow up women’s health care. The primary screenings were 
accomplished in the ROS section of the EHR by the two LVN project staff and follow up need 
was indicated by four provider staff. 39 of the 158 patients had urine or serum hCG lab tests 
within the last few months. Some of the sample patients refused screening procedure due to 
personal circumstances (single, not sexually active, etc.). However, this was unclear because 
documentation did not require providers specify these reasons and lack of access to first-hand 
provider-patient counseling. One primary reason many of the providers reported was that many 
patients already had children and families and said they did not plan to have more. In order to 
understand why certain patients did not receive testing or screening, further investigation could 
be done. There were likely reasons provided during the patients visit with the provider that 
testing was not needed. 
Table 3 
Reasons That Patient did not Need Follow-Up 
Reason n = 158 
Post menopause 33 
Surgical hysterectomy 15 
Using birth control 13 
Surgical tubal ligation 11 
Currently menstruating 10 
Refused program need 9 
Abstinence from sex 8 
Same sex partner 5 
Irregular menses 3 
Polycystic ovarian syndrome 1 
Note. Patients currently menstruating were excluded from follow up. Birth control in this table 
was counted as using prescription methods from a provider.  
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Out of the 158-patient sample, 50 patients were identified as needing follow up. These 50 
patients were forwarded to CM for follow up purposes via email or telephone that was provided 
by the organization’s EHR. CM was able to reach 39 of these 50 via phone or email to find out 
their pregnancy plans for the future. Eleven patients reported they were not sexually active. Nine 
patients stated they used other birth control methods with their partners. Six patients reported 
they have same sex partners. Three reported seeing or having an OBGYN care provider already. 
One patient reported they were unable to have children but did not know why. Three clients 
stated they did not have an intimate partner. Two patients stated they adopted their children and 
did not plan to have their own children. Four patients were noted to need an OBGYN provider 
and were referred to one of the local clinics outlined in the educational tri-fold. 
Discussion 
The most important part of this QI project was the implementation of a pregnancy bridge 
program for patients. The major practice change for female psychiatric patients was the 
recommended inclusion of OBGYN health care. The project site did not offer this type of service 
previously. The provider staff were able to screen a large sample of patients over 10 weeks and 
provided important education and follow up as needed. These patients had the option to connect 
with pre-conception services in the community if indicated. The primary practice change at the 
microsystem level was utilization of a checklist to remind providers to screen for pregnancy 
intention. Ordering labs was accomplished per institution policy and at the discretion of provider 
counseling. From pre and post analysis, these rates showed an increase from data that was 
gathered prior to this intervention. Patients who did not have a recent pregnancy test were 
identified for follow up as long as they did not have some other reason (such as hysterectomy or 
tubal ligation). The core of this project was adherence to recommendations of the CDC and 
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ACOG and the highest levels of evidence found relating to process change. Literature focusing 
on patients with bipolar disorder involving a pregnancy care bridge was not found despite the 
clear evidence of this problem in research. Other studies primarily focus on depression and how 
it relates to pregnancy outcome. 
Barriers and Limitations 
Staff participation and adherence to methods was required for project success. The LVN 
staff was responsible for initiating the checklist on identified patients after they check in to the 
OMHC. Usually, the LVNs were responsible for tracking and accomplishing screening 
procedures, including one key question, and possibly either blood or urine hCG screenings on 
female patients. Finally, one CM was used to track and follow up with patients regarding 
OBGYN care. Accurate patient data for this project is required to provide useful information for 
the organization and nursing practice. Another barrier is the patients’ right to refuse any part of 
the process by the LVNs or mental health care prescribers regarding pregnancy 
recommendations. In order to ensure process is maintained, weekly follow up and the DNP 
student gave feedback to staff even when social distancing was mandated.    
Local clinic leadership was hesitant to sign off on project details and steps until higher 
tiers of the organization had approved. Even after the organizational leadership at their treatment 
team meeting approved the project, there was clear disconnection between the higher and lower 
levels of leadership. Only some staff at the local clinic were present for the TCC presentation. 
Most of the staff that participated in this project were not at the TCC presentation.  
Time constraints for providers and project timeline for this project were a big barrier. 
Additional time would be optimal to capture more patients and work out kinks in the process as 
well as further clarify the project checklist. Many staff were resistant to using the checklist when 
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it came to implementation time. One of the LVNs stated, “I don’t have time for all that.” This 
LVN was subsequently dropped from the project and another prescriber was picked up for 
implementation. This LVN along with one of the provider staff gave the impression they did not 
have enough time to fill out the checklist.  
The QI project site was a large, multi-tiered organization with many different 
departments and leadership chains. Implementation of anything outside a checklist would not be 
feasible due to time constraints. In order for something as simple as the addition of a prompt in 
the electronic health record (EHR) change would likely take months to pilot and eventually 
implement with this project site’s structural barriers. Ultimately, the addition of something in the 
EHR would possibly facilitate some aspects of the process change in the future.  
Project staff required constant education and orientation to the goal of the project and use 
of the checklist and educational material. All providers had trouble understanding process 
changes and the goals of the project for several weeks. Most providers are scheduled with a 
patient every 30 minutes or hour during the day, making it difficult to follow up frequently. The 
checklist proved to be cumbersome and could continue being revised. One primary revision to 
the list was made to ease use for the providers (Appendix V). The checklist was simplified by 
creating common items so that providers could circle them and blank space and columns were 
reduced. Unfortunately, this new list was sent out right before the clinic changed its processes 
due to COVID19. In late March, provider guidance was no longer face-to-face throughout the 
week.  
Another problem was provider turnover or absence. One of the initial providers went on 
pregnancy leave near the first week of implementation, so another prescriber staff was added in 
her place. Another provider went on vacation during the COVID19 outbreak and was unable to 
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return due to travel restrictions. Several staff also took paid time off during implementation of 
the project. Rotating schedules of providers and absenteeism affected the workflow and caused 
difficulty in accurate patient count. During the project, some of the project staff took paid time 
off or went on leave. One of the providers initially selected had to go on maternal leave. Another 
provider was out of town when travel restrictions went into place for COVID19. Staff selected 
for the project were regularly out of direct care at the clinic after the pandemic forced the 
organization to implement safety protocols. For these reasons, it is almost impossible to 
determine what an accurate count should be for this project. 
Patient selection related to diagnosis codes were problematic and caused confusion 
among providers. Diagnoses such as schizophrenia, bipolar type (ICD-10 diagnosis code 25.0), 
were not anticipated as being part of the project but were included. Several patient checklists 
were filled out with diagnosis code of depression as well (ICD-10 diagnosis code 33.X). These 
patients should be included in future data collection as the educational material is applicable to 
all patients. There is a lot of gray area and overlap when it comes to psychiatric diagnoses, and 
many patients have symptoms of multiple disorders. Nonetheless, these patients should be 
included as additional education, screening, and provider collaboration still applies.   
Obtaining data for this project was met with organizational resistance and large time 
requirements. Data requests to the organization’s information technology (IT) department had to 
be approved by higher levels of leadership. The initial IT report requested took 2 months to 
receive. Even with this report, there were limitations on the data that was generated by IT. The 
center was only able to report boxes checked or very concrete data. Details in the notes of 
providers for patients included in the project were not able to be collected. Even with this report, 
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it was difficult to tell if primary diagnoses were captured, as patients often had many more than 
one.  
The organization imposed regulation regarding student computer access. Computer and 
EHR permissions were limited due to student/non-essential staff status. This meant some 
functions were not available to the DNP student for data gathering. With computer access, 
retrieving EHR information was very tedious. After March 20, 2020, the DNP student collected 
data by going through one patient record at a time, viewing the ROS and provider evaluation 
notes. Many patients were unable to be contacted. Distinguishing how relevant cancelations, no 
shows, and other factors for data collection skew project data are difficult to discern. 
There are hard to identify gaps in the data collected for this project due to inability to be 
present for provider counseling. A large portion of patients that did not have lab testing even 
though they met theoretical criteria. Likely, the information supplied by the patient to the 
provider indicated the patient did not need follow up for pregnancy plan. Providers often did not 
order hCG testing on their patients and it was unclear without further investigation and talking 
with the provider about the patient why this occurred. There are likely other reasons for why 
patients were not requiring testing, such as the patient not being sexually active. This type of 
information was not reflected in the patient chart. However, it is impossible to know all reasons 
without being present for every patient screening and visit. This setting had its own standardized 
window for lab testing, which was every year and sooner if indicated by the patient.   
The Novel Coronavirus 2019 
The novel coronavirus (COVID19) had tremendous implications in this project. The 
pandemic hit hard around mid-March in the United States, with most Texas cities shutting down 
large public gatherings. The outbreak caused most medical facilities, including this project site, 
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to focus on changing structure and taking safety precautions to avoid spread of the virus. 
Leadership of this organization first called for limitation of student in house hours and 
internships starting on March 20, 2020 (see Appendix Q). After this point, contact with the 
project site and project staff was conducted through email and phone since most staff were 
teleworking from home. Furthermore, staff roles were changed as described below. 
At this OMHC, a screening tent was set up at the front of the building to screen patients 
for the symptomatology related to COVID19. Starting the week 6 of implementation (March 23, 
2020), both of the LVN and RN staff selected and spearheading the ROS/screening part of the 
project had to take turns sitting in this tent to do screening for the new virus. From then on, both 
project staff were only doing vital signs for patients and told by clinic leadership not to perform 
patient focused ROS. Initially, the LVN staff would screen the patient and do any lab collection 
needed. As of the 23, these staff reported only doing vital signs for patients and outdoor 
COVID19 screening.  
Clinic prescribers were transitioned to tele-health only. On March 23, 2020, all providers 
started seeing patients via phone or video call. The providers were also rotating shifts; one week 
they would be in clinic and the next they would be at home conducting patient interviews via 
telehealth. The complete absence of face-to-face time made giving patients meant predesigned 
educational material had to be emailed to patients. In addition, provider caseloads were able to 
be determined via remote access EHR starting March 23, 2020 for this project. Some patients did 
not have emails in the EHR for providers. The clinic staff was able to adapt to send information 
to people without face-to-face contact. Access to phone or email for some patients was also 
problematic during the pandemic. Some patients were not able to obtain or receive education or 
counseling as they did not answer their phones or provide email addresses.  
PSYCHIATRIC PATIENT PREGNANCY BRIDGE PROGRAM 34 
The primary issue with the pandemic was lack of person-to-person contact. Verbal 
counseling and in person services are no doubt better for patient outcomes. Services such as 
blood draws and injections were accomplished for those patients that absolutely needed to come 
into the clinic. Due to the clinic’s changes, the project was transitioned to online only after 
March 20, 2020. All patient data was gathered from with one or two providers after this date, as 
the DNP student was able to contact all providers via phone and email. Updates for the project 
staff were conducted via phone and email primarily. Brief follow up in person at the OMHC was 
allowed from time to time. 
Recommendations 
Capturing this highly specific population of expecting mothers struggling with mental 
disorders remains elusive. This is in large part due to the nature of pregnancy planning by the 
public. This project made it clear these clients will always be difficult cohort to study. Meeting 
goals for this process change require continued testing and reevaluation to determine 
effectiveness and best implementation. To continue implementation of this project, the 
organization must continue to promote the project resources and make them easily accessible for 
staff and patients. Another full-time employee could conduct care coordination and proper 
follow up. Furthermore, provider completion rates depend on consistent education and 
involvement from all levels of leadership. 
The checklist used in this project was updated once and could be further refined in the 
future. Unfortunately, time constraints and retraining staff make this difficult. With additional 
time and organizational buy in from all levels, it would be ideal to implement this project as part 
of the EHR. Changes in the clinic’s EHR would streamline this process change. However, before 
piloting implementations and revising the process over time, it would be unclear how to 
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implement a change in the EHR. Data specialists, the EHR, and the organization would have to 
confer. More data and time would aid in determining whether this type of change is indicated 
and how best to accomplish these goals. There would be lengthy time and testing requirements 
outside of the scope of the timeframe for this process change. A standing order set would be 
required for all patients to have blood or urine pregnancy testing. However, this is clearly not 
necessary for most patients. Testing and follow up is left to interaction between the patient and 
provider and without witnessing all that happens during counseling, it is very difficult to 
determine appropriate follow of these patients.  
This project demonstrated how difficult it is to establish and capture patients for this type 
of following for many reasons. Firstly, appointments tend to be every month or more. It is 
possible that women will become pregnant in between appointments. The data collected here 
provides a single snapshot, while effective follow up need to be continuous. Therefore, it would 
be difficult to ensure these patients receive proper care at one point in time. Even if testing and 
follow up was done at the time of this project, things could easily change for the patient in the 
future. Much responsibility lies on the individual, as healthcare providers spend so relatively 
little time with their patients. Covering all patient needs will always be difficult. 
All patients, regardless of age and diagnosis, should be interviewed for pregnancy plan. 
By no means, should only patients with a certain diagnosis receive pre-pregnancy counseling. 
Both men and women should be educated and followed for risk. The more patients that are 
educated regarding the known risks of medications, the better the community outcomes will be 
for this community. Research has shown that many medications are transported in body fluids 
(Grover & Avasthi, 2015; Stahl, 2017) and affect fetal outcomes.  
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Pre-intervention, medication consent forms were accomplished on 97% of patients. The 
purpose of this form is to serve as proof the patient gave consent to take medications which may 
cause harm to the fetus.  The consent information is in accordance with guidelines by the ACOG, 
is meant to advise patients of the risk of medications, and recommends future mothers find a 
primary care provider for women’s health purposes.  
The sustainability of this DNP project is dependent on the staff and organization 
overcoming barriers and refining the process. The pilot program results suggest the importance 
of refining the process and regular staff training. It is critical that staff understand how to use 
new materials and the goal of new processes. Further staff teaching about the importance of 
depression screening, the impact on patient outcomes, and meeting national accreditation 
guidelines and recommendations may further improve the likelihood of project sustainability. 
Continuous assessment of staff adherence towards new interventions can further succeed 
completion rates of the GDS. Additionally, developing ready-made admission and discharge 
packets to include the GDS and depression education handouts may improve the rate of 
completion by nursing staff upon patient admission and discharge.  
Implications for Practice 
Due to the nature of mental illness and its ramifications, this population remains elusive 
when it comes to pregnancy plan and ease of follow up. Many patients with mental health 
disorders are homeless or in another living situation which prevents effective planning and or 
follow up. Hypersexuality and unplanned pregnancy and is a frequent characteristic of bipolar 
disorder and is likely part of the problem resulting in high unplanned pregnancy rates (Dinc et 
al., 2019). 
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Revision of checklists is critical and described by the ACOG (2016) in order to improve 
and streamline processes in development. Several changes to the checklist could be made to 
decrease provider workload and confusion. Design changes such as including more options for 
providers to circle and write would reduce workload and improve ease of use for project staff. 
There were also several useful data points that were originally omitted from the checklist for this 
project that were obtained through lookup in the organization’s EHR. This included, age, 
ethnicity, and gender that were added to the checklist revision.  
Originally, the idea was to conduct urine hCG tests on all females for pregnancy. This 
would require a standing order set as providers ordered tests depending on patient history and 
interview responses to pregnancy planning questions. Results from this project show that hCG 
positive rates would be very low on a large sample. After a few weeks of data collection for this 
project, it was evident that urine screening for most patients is not necessary. Even when hCG 
testing was accomplished, it is hard to say what a sufficient window of time is. Patients tested the 
day of appointment could become pregnant tomorrow. The data from this project provides a 
screenshot of data, whereas these patients should be continuously followed. A larger sample 
would result in more patients needing follow up and planning care. 
This organization could hire one full time employee to conduct follow up for pregnancy 
planning for their patients. Only four providers were selected for this pilot, so following all 
patients from all providers would result in many times the sample amount in this DNP project. 
Tracking and following up properly with all of the patients that come through this clinic would at 
least require another full-time employee. It is clear a select few patients need further monitoring. 
Therefore, process change in the future is still appropriate, due to the lack of a pregnancy care 
bridge at this project site. However, as outline previously, there are many ways to improve the 
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methodology. At the very least, this project encourages providers to provide more 
comprehensive pre-pregnancy planning.    
This project is a good example of where the DNP degree fits into real applications. The 
DNP is beneficial for organizations that wish to increase patient health and have clinically 
focused problem solvers. DNP prepared nurses can look critically at practices that need change, 
identify gaps in knowledge, and work to bridge these chasms to improve organization flow and 
health outcomes. This requires nurses be familiar with clinical care, examine the highest tiers of 
literature, and identify those guidelines that need to be integrated into routine.  
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